Bilge Kocabiyik
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Bilge Kocabiyik has a total of 6 co-authors. Here are the top co-authors by number of shared publications:
- Burcin Irem Abas
Department of Medicinal Biochemistry, School of Medicine, Aydin Adnan Menderes University, Efeler, Turkey
2 shared publications - Ozge Cevik
Aydin Adnan Menderes Universitesi
2 shared publications - Ayşe Anık
Department of Pediatrics, Division of Neonatology Aydın Adnan Menderes University Faculty of Medicine Aydın Turkey
1 shared publication - Erkan Gumus
Department of Histology and Embryology, School of Medicine, Aydin Adnan Menderes University, Aydin, Turkey
1 shared publication - Gulen Melike Demirbolat
ACIBADEM UNIVERSITY, FACULTY OF PHARMACY
1 shared publication - Melike Cenik
Department of Molecular Biotechnology, Graduate School of Health Sciences, Aydin Adnan Menderes University, Aydin, Turkey
1 shared publication
Latest Publications
- 17 November 2022
- Published by Taylor & Francis in Journal of Obstetrics and Gynaecology
- Vol. 42 (8) , 3568-3576
Human wharton-jelly mesenchymal stromal cells reversed apoptosis and prevented multi-organ damage in a newborn model of experimental asphyxia
In this study, the effect of applying wharton jelly mesenchymal stromal cells (WJ-MSC) isolated from the human umbilical cord tissue on the neonatal mouse model caused experimental asphyxia in mice was investigated. WJ-MSC surface markers (CD44, CD90, CD105) were characterised by immunofluorescence staining, and pluripotency genes (Nanog, Oct-4, Sox-2) were characterised by qPCR. Blood, prefrontal cortex, cerebellum, hippocampus, lung, heart, kidney, and liver tissues were analysed twenty days after subcutaneously administered WJ-MSC. WJ-MSC administration significantly decreased serum TNF-α, NSE, GFAP, and IL-6 levels in the asphyxia mice. It was determined that WJ-MSC application in tissues accelerated cell regeneration and decreased oxidative stress. In conclusion, this study showed that multiorgan damage in asphyxia could be prevented by applying WJ-MSC at an early stage. Therefore, WJ-MSC application in infants with neonatal asphyxia in the clinic may be an innovative method in the future. GRAPHICAL ABSTRACT
- 17 November 2022
- Published by Taylor & Francis in Journal of Obstetrics and Gynaecology
- Vol. 42 (8) , 3568-3576
Human wharton-jelly mesenchymal stromal cells reversed apoptosis and prevented multi-organ damage in a newborn model of experimental asphyxia
In this study, the effect of applying wharton jelly mesenchymal stromal cells (WJ-MSC) isolated from the human umbilical cord tissue on the neonatal mouse model caused experimental asphyxia in mice was investigated. WJ-MSC surface markers (CD44, CD90, CD105) were characterised by immunofluorescence staining, and pluripotency genes (Nanog, Oct-4, Sox-2) were characterised by qPCR. Blood, prefrontal cortex, cerebellum, hippocampus, lung, heart, kidney, and liver tissues were analysed twenty days after subcutaneously administered WJ-MSC. WJ-MSC administration significantly decreased serum TNF-α, NSE, GFAP, and IL-6 levels in the asphyxia mice. It was determined that WJ-MSC application in tissues accelerated cell regeneration and decreased oxidative stress. In conclusion, this study showed that multiorgan damage in asphyxia could be prevented by applying WJ-MSC at an early stage. Therefore, WJ-MSC application in infants with neonatal asphyxia in the clinic may be an innovative method in the future. GRAPHICAL ABSTRACT
- 27 August 2021
- Published by Springer Nature in Journal of Pharmaceutical Innovation
- Vol. 17 (3) , 931-939
Development of a New Drug Delivery System from HELA-Derived Exosomes and the Effect of Docetaxel-Loaded Exosomes on Mitochondrial Apoptosis
- 27 August 2021
- Published by Springer Nature in Journal of Pharmaceutical Innovation
- Vol. 17 (3) , 931-939
Development of a New Drug Delivery System from HELA-Derived Exosomes and the Effect of Docetaxel-Loaded Exosomes on Mitochondrial Apoptosis